SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
F-6 POS	Post-effective amendment to a previously filed F-6	Jun 11, 2008	View HTML 0001193805-08-001549.pdf 0001193805-08-001549.rtf
FWP	FWP	Nov 17, 2021	View HTML 0001193125-21-331817.pdf 0001193125-21-331817.rtf 0001193125-21-331817.xls
NT 10-K	Notification that form 10-K will be submitted late	May 03, 2021	View HTML 0001193125-21-146673.pdf 0001193125-21-146673.rtf 0001193125-21-146673.xls
NT 10-Q	Notification that form type 10-Q will be submitted late	Nov 09, 2007	View HTML 0001193125-07-241932.pdf 0001193125-07-241932.rtf 0001193125-07-241932.xls
NT 20-F	NT 20-F	Dec 30, 2005	View HTML 0001144204-05-041571.pdf 0001144204-05-041571.rtf 0001144204-05-041571.xls
POS AM	Post-effective amendment to an S-Type filing	Jun 20, 2008	View HTML 0001193125-08-136862.pdf 0001193125-08-136862.rtf 0001193125-08-136862.xls
POS AM	Post-effective amendment to an S-Type filing	Jun 20, 2008	View HTML 0001193125-08-136863.pdf 0001193125-08-136863.rtf 0001193125-08-136863.xls
POS AM	Post-effective amendment to an S-Type filing	Jul 03, 2008	View HTML 0001193125-08-146757.pdf 0001193125-08-146757.rtf 0001193125-08-146757.xls
PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Oct 08, 2010	View HTML 0001193125-10-226911.pdf 0001193125-10-226911.rtf 0001193125-10-226911.xls
PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Sep 29, 2011	View HTML 0001193125-11-259968.pdf 0001193125-11-259968.rtf 0001193125-11-259968.xls

Data provided by Kaleidoscope.